WHO vaccine-preventable diseases: monitoring system. 2019 global summary

Last updated 10-December-2019 (data as of 10-December-2019)
Next overall update June 2020
EPI mother and child logo         
Select a country

Development status: developing GNI / capita (US$): 4'1901 Infant (under 12 months) mortality rate: 142
GDP / capita (US$): 6'8501 Child (under 5 years) mortality rate: 172

Population data in thousands3

  2018  2017  2016  2015  2014  2000  1990  1980 
Total population 196  195  195  194  192  174  163  156 
Births
Surviving infants
Pop. less than 5 years 28  28  28  29  29  26  23  24 
Pop. less than 15 years 75  75  75  75  74  71  66  72 
Female 15-49 years 90  90  90  90  90  83  78  68 

Number of reported cases

(Click for retrospective incidence data for Samoa)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  376 
Mumps
ChartChart
  50 
Pertussis
ChartChart
  326  113 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Samoa)
Vaccine year result method % card seen                                                
BCG 2012  90     67  99*  95  82  89  95  97  97  72 
DTP1 2012  88     67  44  97  99*  99*  99  94 
DTP3 2012  64     67  44  90  90  94  91  99*  90  29 
IPV1          46  90  94 
HepB_BD          59  95  91  85  82  99 
HepB3 2012  64     67  44  84  90  94  91  96 
Hib3 2012  64     67  44  84  90  94  91 
JapEnc         
MCV1          40  80  77  78  91  93  89 
MCV2          28  78  59  63  78 
MenA         
PCV1         
PCV2         
PCV3         
Pol3 2012  62     67  44  90  90  94  91  99*  88  29 
Rota1         
RotaC         
RCV1          40  80  77  78  91 
TT2plus 2012  24     67  50  99*  70 
PAB         
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid July 2020

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Samoa)
BCG
ChartChart
  62  83  76  83  89  97  97  72 
DTP1
ChartChart
  56  84  95  89  88  99  96  54 
DTP3
ChartChart
  34  74  80  84  81  98  90  29 
HepB3
ChartChart
  34  74  80  84  81  93 
HepB_BD
ChartChart
  46  81  77  72  69  86 
Hib3
ChartChart
  34  74  80  84  81 
IPV1
  46  81  94 
MCV1
ChartChart
  31  58  68  69  82  93  89 
MCV2
ChartChart
  13  42  44  48  63 
PCV3
 
Pol3
ChartChart
  31  71  77  81  78  98  88  29 
RCV1
ChartChart
  31  58  68  69  82 
RotaC
 

Click to download WHO-UNICEF coverage estimates data for PAB time series.
Click to download WHO-UNICEF coverage estimates data for HPV time series.

Number of districts in the country 10  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 0
From 80 to 89% 0
From 50 to 79% 20
Less than 50% 80
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2018 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwP 5 years; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
HepB_Pediatric birth; Yes
IPV 14 weeks; Yes
MMR 12, 15 months; Yes
OPV 6, 10, 14 weeks; Yes
Td 28 weeks; +2, +3 months; +1, +1 year; Yes

Immunizaton indicators

Indicator Expected answer 2018  2017  2016  2015  2014  2013  2012 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number   2'018  2'018  2015-2016  2014-2016  2013-2015   
Nº of districts with microplans that include activities to raise immunization coverage number 10  10    10  10   

System performance

Total Nº districts in country number 10  10  10  10  10 
Nº districts with DTP3 coverage >=80% number  
% of districts with DTP3 coverage >=80% From 0 to 100% 40  70  70  80  100   
Nº districts with measles (MCV1) coverage >=95% number  
% of districts with MCV1 coverage >=95% From 0 to 100% 10  20  40  56   

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  No  Yes      No 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  No    Yes      Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%             100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  Yes  Yes  No  Yes  Yes 

Sources

 1  "The 2019 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  UN Inter-agency Group for Child Mortality Estimation (https://childmortality.org/data)  
 3  "United Nations, Population Division. The World Population Prospects - the 2019 revision". New York, 2019.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.